Minerva Neurosciences Q2 2024 GAAP EPS $(1.09) Misses $(0.73) Estimate, Cash, Cash Equivalents And Restricted Cash At June 30, 2024 Were Approximately $31M
Portfolio Pulse from Benzinga Newsdesk
Minerva Neurosciences reported a Q2 2024 GAAP EPS of $(1.09), missing the estimate of $(0.73). The company had approximately $31M in cash, cash equivalents, and restricted cash as of June 30, 2024.
August 06, 2024 | 11:43 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Minerva Neurosciences reported a Q2 2024 GAAP EPS of $(1.09), missing the estimate of $(0.73). The company had approximately $31M in cash, cash equivalents, and restricted cash as of June 30, 2024.
The significant miss on the EPS estimate is likely to negatively impact investor sentiment and the stock price in the short term. However, the company's cash position provides some financial stability.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100